SCHEMBL21749394

SCHEMBL21749394

Cc1cc(N)cc(C)c1Cc1cc(C(C)C)c(=O)[nH]n1

nearest known ligand 0.53

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
THRB P10828 17/20 0.53
THRA P10827 15/20 0.53
AR P10275 1/20 0.33
CYP2C9 P11712 1/20 0.33
UGT1A1 P22309 1/20 0.33
ABCG2 Q9UNQ0 1/20 0.33
SLCO1B1 Q9Y6L6 1/20 0.33
PARP1 P09874 1/20 0.32
PRMT5 O14744 1/20 0.31
WDR77 Q9BQA1 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21749446 0.86 THRB (0.59) THRBTHRAARPARP1
SCHEMBL24032753 0.86 THRB (0.56) THRBTHRAAR
SCHEMBL2922891 0.85 THRB (0.68) THRBTHRACYP2C9UGT1A1ABCG2
SCHEMBL21840370 0.78 THRB (0.48) THRBTHRAPRMT5WDR77
SCHEMBL24032735 0.77 THRB (0.55) THRBTHRA
SCHEMBL21840363 0.75 THRB (0.48) THRBTHRACYP2C9UGT1A1ABCG2
SCHEMBL31054376 0.75 THRB (0.46) THRBTHRA
SCHEMBL21749488 0.75 THRB (0.48) THRBTHRAARPARP1
SCHEMBL38650728 0.75 THRB (0.45) THRBTHRA
SCHEMBL24032754 0.75 THRB (0.43) THRBTHRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112805005-B Thyroxine receptor beta agonist compounds 拓臻股份有限公司 2026-05-12 CN disclosed
EP-3840755-B1 THYROID HORMONE RECEPTOR BETA AGONIST COMPOUNDS TERNS INC (US) 2026-02-18 EP disclosed
US-20250236615-A1 THYROID HORMONE RECEPTOR BETA AGONIST COMPOUNDS Terns, Inc. 2025-07-24 US disclosed
EP-3840755-A1 THYROID HORMONE RECEPTOR BETA AGONIST COMPOUNDS Terns, Inc. (US) 2021-06-30 EP disclosed
CN-112805005-A Thyroxine receptor beta agonist compounds 拓臻股份有限公司 2021-05-14 CN disclosed
US-10800767-B2 Thyroid hormone receptor beta agonist compounds Terns, Inc. (US) 2020-10-13 US disclosed
US-10800767-B2 Thyroid hormone receptor beta agonist compounds Terns, Inc. (US) 2020-10-13 US disclosed
WO-2020041741-A1 THYROID HORMONE RECEPTOR BETA AGONIST COMPOUNDS Terns, Inc. (US) 2020-02-27 WO disclosed
US-20200062742-A1 THYROID HORMONE RECEPTOR BETA AGONIST COMPOUNDS Terns, Inc. 2020-02-27 US disclosed
US-20200062742-A1 THYROID HORMONE RECEPTOR BETA AGONIST COMPOUNDS Terns, Inc. 2020-02-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200062742-A1 THYROID HORMONE RECEPTOR BETA AGONIST COMPOUNDS THRB, THRA, TSHR THRB 1/4885THRA 2/4885AR 263/4885
US-20250236615-A1 THYROID HORMONE RECEPTOR BETA AGONIST COMPOUNDS THRB, THRA, TSHR THRB 1/4885THRA 2/4885AR 263/4885
US-10800767-B2 Thyroid hormone receptor beta agonist compounds THRB, THRA, TSHR THRB 1/4885THRA 2/4885AR 263/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.